Physician profile
Grant H Henry
NPI 1710935234
$4,319.38
in general payments reported to CMS, 2019-2025
37 companies · $662 in 2025
The $662 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $727 · 2021: $318 · 2022: $529 · 2023: $583 · 2024: $684 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $492.52 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $443.69 | 2021-2025 | |
| Lilly USA, LLC | $440.16 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $370.21 | 2019-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $353.29 | 2019-2024 | Evusheld, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $347.27 | 2019-2025 | Arexvy, Shingrix |
| Pfizer INC. | $342.16 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $183.71 | 2019-2025 | |
| Allergan, INC. | $169.49 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.58 | 2019-2024 | Jardiance, Tradjenta |
| Eisai INC. | $127.37 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $126.31 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Bayer Healthcare Pharmaceuticals INC. | $91.81 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $59.19 | 2019-2022 | |
| Boston Scientific Corporation | $57.33 | 2025 | Watchman Flx |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.